‘Shrooms may ease anxiety in cancer patients
According to a study published in the Archives of General Psychiatry (abstract only), hallucinogen psilocybin (which to you and me, is known as “magic mushrooms”) may noticeably reduce anxiety and depression in advanced cancer patients. The 12 patients in the pilot study were less depressed with one moderate dose of psilocybin compared with a placebo.
This isn’t the first time that doctors and scientists researched the effects of hallucinogens on mood and anxiety problems. From the 1950s to the 1970s, doctors experimented with drugs like LSD. But once those drugs hit the streets, strict federal laws regulated the drugs and the medical studies were abandoned.
If medicinal marijuana gets legalized by the federal government, will the next drug legalization fight be over hallucinogens?
Marketplace is on a mission.
We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.
Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?